NCT05042232View on ClinicalTrials.gov

A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19

CompletedOBSERVATIONAL
Enrollment

239

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

May 15, 2022

Study Completion Date

June 14, 2022

Conditions
SARS-CoV-2 Acute Respiratory Disease
Interventions
OTHER

SARS-CoV-2 Positive

Participants who have tested positive for SARS-CoV-2, both with and without symptoms

OTHER

SARS-CoV-2 Negative

Participants who have tested negative for SARS-CoV-2

Trial Locations (1)

78703

Everlywell, Inc, Austin

Sponsors

Lead Sponsor

Everly Health
All Listed Sponsors
lead

Everly Health

INDUSTRY

NCT05042232 - A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19 | Biotech Hunter | Biotech Hunter